Fingerprint
Dive into the research topics of 'Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas
Abraham Jacob, Janet Oblinger, Matthew L. Bush, Victoria Brendel, Griffin Santarelli, Abhik R. Chaudhury, Samuel Kulp, Krista M.D. La Perle, Ching Shih Chen, Long Sheng Chang, D. Bradley Welling
Research output: Contribution to journal › Article › peer-review
32
Scopus
citations